Guide for patients & caregivers

What Does Gleason 6 (Grade Group 1) on a Prostate Biopsy Mean?

Gleason 6 (Grade Group 1) prostate cancer is the lowest grade. Learn why active surveillance is often discussed, what monitoring involves and when to treat.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does Gleason 6 prostate cancer mean?

A Gleason score of 6 (written 3+3=6), also called Grade Group 1, means prostate cancer was found on biopsy and the cells are the lowest grade, looking the most like normal prostate tissue. The US National Cancer Institute (NCI) describes a score of 6 as low-grade cancer. Low grade suggests the cancer is less likely to grow and spread quickly, but the full risk picture also depends on other findings.

This guide is for adults who have a biopsy report showing Gleason 6 or Grade Group 1. It explains the terms and what monitoring usually involves. It cannot judge an individual's risk or tell anyone which option to choose.

When to get checked sooner

A low-grade result does not mean new symptoms can wait for the next routine check. Seek advice promptly if any of the following happens.

  • Fever and chills within a few days of a prostate biopsy: RadiologyInfo advises calling the doctor immediately or going to the nearest emergency department.
  • Peeing problems that change, get worse or do not feel normal, or blood in the urine or semen: the NHS advises getting these checked.
  • Lower back pain or weight loss without trying: the NHS lists these as possible signs of more advanced prostate cancer, so mention them to the care team without delay.
  • Any worry between check-ups: the NHS says there is no need to wait for the next appointment to raise concerns with the specialist team.

How is the Gleason score worked out?

A pathologist looks at the biopsy samples under a microscope and gives the two most common cell patterns a grade from 3 to 5. Grade 3 looks the most like normal prostate tissue and grade 5 the most abnormal. The two grades are added together, so the scores used today range from 6 to 10.

The NCI describes a Gleason score of 6 as low grade, 7 as medium grade, and 8 to 10 as high grade. Grade Groups simplify this into five groups. Grade Group 1 is a Gleason score of 6 or less; Grade Group 5 is a Gleason score of 9 or 10. So "Gleason 6", "3+3" and "Grade Group 1" describe the same lowest grade.

A biopsy report may also say how many samples (cores) contained cancer and how much of each core was involved. These details, along with PSA and MRI findings, help the specialist judge how much cancer there is, not just its grade.

Is Gleason 6 prostate cancer low risk?

Gleason 6 is the lowest grade, and many people with it are placed in a low-risk group. But risk is not set by the grade alone. The NCI notes that stage and outlook depend on the PSA level, Grade Group, how much of the prostate is affected and whether the cancer has spread, as well as age and other health problems.

The NHS explains that prostate cancer often grows slowly and may never cause problems, while treatments such as surgery and radiotherapy can cause serious and long-lasting side effects, including leaking urine and erection problems. That balance is why monitoring is often discussed for low-grade cancer that has not spread.

A biopsy samples only part of the prostate. This is one reason monitoring includes further tests rather than relying on a single result.

What is active surveillance for prostate cancer?

Active surveillance means not treating the cancer straight away, but checking it regularly so that treatment aimed at cure can start if it shows signs of growing. The NCI's clinician summary describes the aim as avoiding the side effects of treatment in men whose cancer is not progressing, while keeping the ability to cure it if it does.

It is different from watchful waiting. The NHS describes watchful waiting as regular check-ups and blood tests, often with the GP, and is usually aimed at managing symptoms if they appear. Active surveillance involves regular hospital tests and scans. Make sure it is clear which approach is being offered.

What does active surveillance involve?

Sources describe a similar set of checks, although the schedule varies between hospitals and between people. The NCI notes that testing intervals and the criteria for starting treatment have not been fixed by controlled trials, and a Cleveland Clinic urologist describes there being no single agreed schedule.

  • Regular PSA blood tests to follow the trend over time.
  • Digital rectal examinations.
  • Prostate MRI scans, which many programmes now use to watch the prostate.
  • Repeat prostate biopsies, sometimes targeted to areas seen on MRI; Cleveland Clinic describes these as happening every one to three years for many people.
  • In some centres, genomic tests on the biopsy tissue to add information about how the cancer may behave.

When is treatment discussed for Gleason 6 prostate cancer?

The NHS says that if the cancer grows or starts to cause symptoms, the care team will talk about treatment options. In practice, specialists look for signs of change such as a rising PSA trend, a new or growing area on MRI, more cancer in repeat biopsy samples, or a higher grade (for example a pattern 4 appearing) on a later biopsy. The exact triggers vary between teams.

Treatment can also be discussed for personal reasons. Cleveland Clinic points out that surveillance means committing to repeated tests, including biopsies that can be uncomfortable and carry a small risk of infection, and living with an untreated cancer. Some people decide this is not right for them. Options for localised prostate cancer include surgery to remove the prostate and radiotherapy, each with its own side effects to discuss with the team.

Do not stop or change any prescribed medicine because of a biopsy result; talk to the prescriber first.

Questions to ask about a Gleason 6 result

Bring the biopsy report, MRI report and PSA history. These questions can help structure the conversation.

  • How many cores showed cancer, and how much of each was involved?
  • Which risk group am I in, and what else besides the Gleason score decided that?
  • Are you recommending active surveillance, watchful waiting or treatment, and why?
  • What tests will surveillance involve for me, and how often?
  • What changes in PSA, MRI or biopsy would lead you to recommend treatment?
  • Would a second pathology opinion on the biopsy slides be useful in my case?
  • Who is my main contact if I have questions or new symptoms between visits?

How comparing similar cases on SameCase can help

On SameCase, patients and verified doctors share de-identified cases. Seeing how others with Grade Group 1 results described their surveillance schedules, the questions they asked and the points at which treatment came up can help you prepare for your own discussions. Other people's cases cannot predict how your cancer will behave or replace your specialist's advice; we see them as a way to arrive with clearer questions.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning